– USA, FL – Intech, a global quantitative equity manager, announced the appointment of Roz Hewsenian to its Board of Directors, bringing over 40 years of institutional investment experience to Intech during a pivotal moment in the firm’s next phase of growth.
About Rosalind M. Hewsenian
Roz Hewsenian spent 21 years at Wilshire Associates, where she served as Principal, Managing Director, and Board Member. During her tenure, she led consulting efforts for some of the largest institutional investors, most notably serving as the lead consultant to CalPERS. Roz Hewsenian played an important role in shaping CalPERS’ investment strategy, guiding it to full funding on a market-value basis.
“Intech’s distinctive quantitative approach and commitment to the scientific method have truly set it apart,” said Roz Hewsenian. “I’m honored to join the Board at such an exciting time in the firm’s evolution, and I look forward to working closely with the leadership team to continue advancing Intech’s mission of delivering disciplined, innovative solutions that meet the evolving needs of its clients.”
About Intech
Founded in 1987, Intech is a global quantitative equity manager, dedicated to serving institutional and wealth management clients. Pioneering the use of Stochastic Portfolio Theory, Intech seeks to construct portfolios designed to deliver superior risk-adjusted returns for a diverse client base that includes pension funds, sovereign wealth funds, endowments, and foundations. With a steadfast commitment to disciplined risk management and scientific research, Intech manages approximately $11 billion in assets as of June 30, 2024.
For more information: https://www.intechinvestments.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.